Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-Lactamases

Antimicrobial Agents and Chemotherapy
2009.0

Abstract

During a 6-month period, 37/513 (7.2%) Pseudomonas aeruginosa isolates belonging to 13 pulsed-field gel electrophoresis (PFGE) groups from Puerto Rican hospitals were carbapenem nonsusceptible. Seven of 37 isolates from four PFGE groups carried bla(IMP-18), and 25/37 isolates from seven PFGE groups carried bla(KPC). The results indicated the clonal spread of bla(KPC)-positive P. aeruginosa isolates into several Puerto Rican hospitals and the dissemination of bla(IMP-18) and bla(KPC) into genetically unrelated isolates.

Knowledge Graph

Similar Paper

Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 β-Lactamases
Antimicrobial Agents and Chemotherapy 2009.0
First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase
Antimicrobial Agents and Chemotherapy 2007.0
IMP-15-Producing Pseudomonas aeruginosa Strain Isolated in a U.S. Medical Center: a Recent Arrival from Mexico
Antimicrobial Agents and Chemotherapy 2008.0
Detection of KPC in Acinetobacter spp. in Puerto Rico
Antimicrobial Agents and Chemotherapy 2010.0
Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital
Antimicrobial Agents and Chemotherapy 2007.0
Metallo-β-Lactamase Gene bla <sub>IMP-15</sub> in a Class 1 Integron, In 95 , from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico
Antimicrobial Agents and Chemotherapy 2008.0
Full Resistance and Decreased Susceptibility to Carbapenems in IMP-13-Producing Pseudomonas aeruginosa Isolates from an Outbreak
Antimicrobial Agents and Chemotherapy 2010.0
Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-β-Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18)
Antimicrobial Agents and Chemotherapy 2009.0
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals
Antimicrobial Agents and Chemotherapy 2007.0
Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008
Antimicrobial Agents and Chemotherapy 2010.0